Product description

A HIGHLY CONCENTRATED AND RE-ESTERIFIED BIO-MARINE FORMULATION FOR DIABETIC RETINOPATHY (4 CLINICAL STUDIES)

Retinoaspis is a specialized nutraceutical for the prevention and treatment of diabetic retinopathy and retinal vein occlusion.

Retinoaspis manages diabetic retinopathy by supporting the metabolism, structure and function of retinal cells. Retinoaspis has a strong anti-inflammatory effect by promoting the production of anti-inflammatory cytokines. A key anti-inflammatory component is docosahexaenoic acid (DHA), which is a necessary component for the normal function of the organism and cannot be synthesized by itself.

Read more

Specifications

More products from Aniva International SA

View all our products (10)

Products from other suppliers